首页> 外文期刊>BMC Psychiatry >Efficacy and cost-effectiveness of a blended cognitive behavioral therapy for depression in Spanish primary health care: study protocol for a randomised non-inferiority trial
【24h】

Efficacy and cost-effectiveness of a blended cognitive behavioral therapy for depression in Spanish primary health care: study protocol for a randomised non-inferiority trial

机译:西班牙初级卫生保健中抑郁症的混合认知行为疗法的疗效和成本效益:一项针对非劣效性随机试验的研究方案

获取原文
           

摘要

Data from primary health care in Spain show a high prevalence of the major depressive disorder. Blended treatment (combination of face-to-face and online components) seems to be a very promising tool for the optimization and dissemination of psychological treatments in a cost-effective form. Although there is growing data that confirm the advantages of blended therapies, few studies have analyzed their application in regular clinical practice. The objective of the present paper is to describe the protocol for a clinical study aimed at exploring the clinical and cost-effectiveness of a blended cognitive behavioral therapy (b-CBT) for depression, compared to treatment as usual (TAU) in a primary health care setting. A two-arm randomised controlled non-inferiority trial will be carried out, with repeated measures (baseline, 3?months, 6?months, and 12?months) under two conditions: b-CBT and TAU. The b-CBT program will consist in three face-to-face sessions and eight online sessions. The TAU is defined as the routine care delivered by the general practitioner for the treatment of depression in primary care. The primary outcome is a symptomatic change of depressive symptoms on the patient-health questionnaire (PHQ-9). Other secondary outcomes will be considered (e.g., quality of life, treatment preference). All participants must be 18?years of age or older and meet the diagnostic criteria for major depressive disorder according to the Diagnostic and Statistical Manual of Mental disorders 4th edition. 156 participants will be recruited (78 per arm). It is expected that b-CBT is clinically non-inferior when compared to TAU. This is the first study in Spain to use a b-CBT format in primary and specialized care, and this format could be an efficacious and cost-effective therapeutic strategy for the treatment of depression. ClinicalTrials.gov NCT02361684. Registered on 8 January 2015. Currently recruiting participants.
机译:西班牙初级卫生保健的数据显示,严重抑郁症的患病率很高。混合治疗(面对面和在线组件的组合)似乎是一种非常有前途的工具,可以以经济高效的方式优化和传播心理治疗。尽管有越来越多的数据证实混合疗法的优势,但很少有研究分析其在常规临床实践中的应用。本文的目的是描述一项临床研究的协议,旨在探索与认知健康中的常规治疗(TAU)相比,抑郁症的混合认知行为疗法(b-CBT)的临床和成本效益护理环境。将在b-CBT和TAU两个条件下进行一项两臂随机对照非劣效性试验,并重复测量(基线,3个月,6个月和12个月)。 b-CBT计划将包括三个面对面会议和八个在线会议。 TAU定义为全科医生在初级保健中提供的用于治疗抑郁症的常规护理。主要结果是患者健康调查表(PH​​Q-9)上抑郁症状的症状变化。将考虑其他次要结局(例如生活质量,治疗偏爱)。所有参与者都必须年满18岁,并且符合《精神障碍诊断和统计手册》第4版中关于重度抑郁症的诊断标准。将招募156名参与者(每人78名)。预计与TAU相比,b-CBT在临床上不会逊色。这是西班牙第一项在初级和专科护理中使用b-CBT格式的研究,该格式可能是治疗抑郁症的有效且具有成本效益的治疗策略。 ClinicalTrials.gov NCT02361684。 2015年1月8日注册。目前正在招募参与者。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号